S&P assigns 'A' rating to Fred Hutchinson Cancer Research Center's bonds

S&P Global Ratings assigned and affirmed the "A" rating on Seattle-based Fred Hutchinson Cancer Research Center's following bonds:

  • Series 2017A revenue bonds
  • Series 2017B revenue bonds
  • Series 2017C revenue bonds
  • Series 2015A revenue bonds
  • Series 2011A revenue bonds
  • Series 2009A revenue bonds

The outlook is positive, reflecting the cancer center's strengthening balance sheet in fiscal year 2016 and the subsequent liquidation of a portion of its stock in Seattle-based Juno Therapeutics, which bolstered the cancer center's cash and investments during the past two fiscal years.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars